NEW YORK, Dec. 4, 2015 /PRNewswire/ -- The dramatic
increase in the amount of digitized health data generated each day
brings new possibilities to apply that information to advance
research and understanding in our connected healthcare system.
As a global leader in protecting individual patient privacy, IMS
Health (NYSE: IMS) uses anonymous healthcare data to deliver
critical, real-world disease and treatment insights.
This article excerpt below from CIOStory, written by
Murray Aitken, executive director,
IMS Institute for Healthcare Informatics looks at the societal
value and uses of non-identified health information.
ARTICLE EXCERPT:
Every CIO knows the value and impact that relevant data can have
on driving efficiencies, revenue and achieving organization
objectives. Perhaps no industry has more to gain from the
combination of powerful analytics and meaningful informatics than
the healthcare sector.
The opportunity to close the healthcare gap – the difference
between today's reality and what is possible from a clinical,
patient and economic perspective – remains a real but elusive
promise for all health systems.
As CIOs work more closely with privacy officers, information
security personnel and overall data governance issues, appropriate
management of health information is becoming an increasingly
important component of operating an effective health care
business.
To view the entire article as it appears on CIOStory click
here:
http://ciostory.com/cxo-perspectives/connected-healthcare-the-critical-role-of-non-identified-information
About the IMS Institute for Healthcare Informatics
The IMS Institute for Healthcare Informatics provides key policy
setters and decision makers in the global health sector with unique
and transformational insights into healthcare dynamics derived from
granular analysis of information. It is a research-driven entity
with a worldwide reach that collaborates with external healthcare
experts from across academia and the public and private sectors to
objectively apply IMS Health's proprietary global information and
analytical assets. More information about the IMS Institute can be
found at: http://www.theimsinstitute.org.
About IMS Health
IMS Health (NYSE:IMS) is a leading global information and
technology services company providing clients in the healthcare
industry with end-to-end solutions to measure and improve their
performance. Our 7,500 services experts connect configurable SaaS
applications to 10+ petabytes of complex healthcare data in
the IMS One™ cloud platform, delivering unique insights
into diseases, treatments, costs and outcomes. The company's 15,000
employees blend global consistency and local market knowledge
across 100 countries to help clients run their operations more
efficiently. Customers include pharmaceutical, consumer health and
medical device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available
at www.imshealth.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/connected-healthcare-the-critical-role-of-non-identified-information-300188182.html
SOURCE IMS Health